Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
  1. 4 Open-market sale See Remarks sold 7,043 shares at $3.02 ($21,263)
  2. 4 Open-market sale General Counsel sold 12,109 shares at $3.02 ($36,557)
  3. 4 Grant or award Chief Operating Officer acquired 407,166 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award Director acquired 30,000 shares (grant or award)
  6. 4 Grant or award Director acquired 54,734 shares (grant or award)
  7. 4 Grant or award Director acquired 30,000 shares (grant or award)
  8. 4 Grant or award Director acquired 47,667 shares (grant or award)
  9. 4 Grant or award Director acquired 49,434 shares (grant or award)
  10. 4 Grant or award Director acquired 30,000 shares (grant or award)
  11. 4 Grant or award Director acquired 30,000 shares (grant or award)
  12. 4 Grant or award Director acquired 30,000 shares (grant or award)
  13. 4 Grant or award Director acquired 30,000 shares (grant or award)
  14. 4 Open-market sale Chief Financial Officer sold 1,477 shares at $2.88 ($4,257)
  15. 4 Open-market sale See Remarks sold 357 shares at $6.45 ($2,301)
  16. 4 Open-market sale See Remarks sold 801 shares at $6.45 ($5,163)
  17. 4 Open-market sale See Remarks sold 767 shares at $6.45 ($4,944)
  18. 4 Open-market sale CEO sold 2,253 shares at $6.45 ($14,523)
  19. 4 Open-market sale General Counsel sold 587 shares at $6.45 ($3,784)
  20. 4 Open-market sale See Remarks sold 655 shares at $6.53 ($4,276)

Page 4 of 21 · 406 filings